US Business
Lilly’s Obesity Pill Approval Kicks Off New Front in Weight-Loss Drug Wars
The drugmaker’s pill will take on a rival from Novo Nordisk in the booming multibillion-dollar obesity drug market.
Articles by Erin Slifka
Chamber Updates
Ambassador Spotlight: Kennedy Krokroskia, KOAM-TV
Meet Kennedy Krokroskia, a Marketing Consultant for KOAM-TV! She’s the most recent Joplin Area Chamber of Commerce Ambassador and has become frequent attendee at networking events. She brings a strong commitment to community, connection, and […]
Chamber Updates
Monthly Chamber Membership Renewals
Thank you to every member who renewed their membership this past month! And thank you to our renewals sponsor, Southwest Missouri Bank. 2019 Phoenix Home Care and Hospice 1957 Pinnacle Bank 1988 Pro Musica 1959 R.E. […]
Chamber Updates
March 2026 Ribbon Cuttings
Congratulations to all our members who recently celebrated their accomplishments with ribbon cuttings! Down Syndrome Group of the Ozarks Sarah Vacca, Community Engagement Coordinator Hosted at The Boutique Marketplace Too 613 S. Main Street Celebrating the […]
Chamber Updates
Welcome New Members
The Chamber’s Board of Directors and staff are pleased to welcome our newest Chamber members! Please keep these and all members in mind when looking for goods and services. Skin & Body Aesthetics Medical Spa […]
US Business
America Now Has an EV Rust Belt. High Gas Prices Won’t Rescue It.
GM supplier Magna is stuck with a plant built to churn out parts for battery-powered pickups. “The magnitude of uncertainty is unparalleled,” said its CEO.
US Business
Your Summer Travel Is About to Be Hit With Fuel Surcharges
Rising prices for jet fuel are expected to cost carriers hundreds of millions of dollars. To cope, they’re raising fares and charging travelers more fees.
US Business
The Year Is Off to the Strongest Start for Big Deals Ever
Companies are plowing ahead with corporate tie-ups and investments despite a war and slumping stocks.
US Business
Big Drug Companies Hunting for Deals Are Lowering Their Sights
About three-quarters of pharmaceutical deals this year have been between $1 billion and $10 billion.
US Business
Oracle Lays Off Workers Amid Heavy AI Investment
Investors see the database firm as a barometer of the financial prospects for artificial intelligence. Oracle’s stock was up 5%.